IRCT20190831044650N2
Completed
未知
Investigating the changes of Tumor necrosis factor-a and Interleukin-10 after 8 weeks of regular Pilates exercise and vitamin D intake in overweight men
Qaemshahr branch, Islamic Azad University0 sites56 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Obesity and overweight.
- Sponsor
- Qaemshahr branch, Islamic Azad University
- Enrollment
- 56
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Being overweight
- •Not having regular exercise for the past six months
- •Ability to perform exercise training
- •Not having cardiovascular disease
- •Not having hypertension
Exclusion Criteria
- •Use of specific drugs
- •Use of supplement
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19COVID-19.COVID-19U07.1IRCT20200312046749N1Tehran University of Medical Sciences80
Not yet recruiting
Not Applicable
Role of certain blood tests(serum TWEAK and hematologic markers) in predicting the severity of acute pancreatitisHealth Condition 1: K85- Acute pancreatitisCTRI/2020/01/022591JIPMER intrumural fund
Recruiting
Not Applicable
Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patientsfertilityreproduction10013356NL-OMON33788Erasmus MC, Universitair Medisch Centrum Rotterdam20
Active, not recruiting
Phase 1
Scintigraphic detection of tumor necrosis factor with radioactive labeled TNFa-blocker in patients with active rheumatoid arthritis and active axial and peripheric spondyloarthropathy.EUCTR2009-017998-37-BEGhent University Hospital36
Completed
Not Applicable
Anti-tumour necrosis factor (anti-TNF) therapy over two years increases body fat mass in early rheumatoid arthritisRheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisISRCTN39045408Karolinska University Hospital (Sweden)40